An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells

Immunology Letters

Volumn 138, Issue 2, 2011, Pages 169-178

  Hwang, Insun ^a   Ahn, Ginnae ^a   Park, Eunjin ^a   Ha, Danbee ^a   Song, Jie Young ^b   Jee, Youngheun ^a  

^a Jeju National University   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Acidic polysaccharide; Central nervous system (CNS); Experimental autoimmune encephalomyelitis (EAE); Panax ginseng

Indexed keywords

GAMMA INTERFERON; GINSAN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GROWTH INHIBITION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION;

ANIMALS; AUTOIMMUNITY; CELL PROLIFERATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; PANAX; PLANT EXTRACTS; POLYSACCHARIDES; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 79959558099     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.04.005     Document Type: Article

References (33)

1. Steinman L. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 1999, 24(3):511-514.
2. Fernandez-Martin A., Gonzalez-Rey E., Chorny A., Ganea D., Delgado M. Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis. Eur J Immunol 2006, 36(2):318-326.
3. Stüve O., Youssef S., Weber M.S., Nessler S., von Büdingen H.C., Hemmer B., et al. Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity. J Clin Invest 2006, 116(4):1037-1044.
4. Kopf H., de la Rosa G.M., Howard O.M., Chen X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol 2007, 7(13):1819-1824.
5. Putheti P., Pettersson A., Soderstrom M., et al. Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J Clin Immunol 2004, 24(2):155-161.
6. Read S., Malmström V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000, 192(2):295-302.
7. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001, 182:18-32.
8. Lee Y.S., Chung I.S., Lee I.R., Kim K.H., Hong W.S., Yun Y.S., et al. Activation of multiple effectors pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res 1997, 17(1A):323-332.
9. Yun Y.S., Lee Y.S., Jo S.K., Jung I.S. Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as an immunomodulator. Planta Med 1993, 59(6):521-524.
10. Ahn J.Y., Song J.Y., Yun Y.S., Jeong G., Choi I.S. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immunol Med Microbiol 2006, 46(2):187-197.
11. Marta M., Andersson A., Isaksson M., Kämpe O., Lobell A. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur J Immunol 2008, 38(2):565-575.
12. Dzopalic T., Dragicevic A., Vasilijic S., Vucevic D., Majstorovic I., Bozic B., et al. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability. Int Immunopharmacol 2010, 10(11):1428-1433.
13. Zhang X., Jin J., Tang Y., Speer D., Sujkowska D., Markovic-Plese S., et al. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 upregulation. J Immunol 2009, 182:3928-3936.
14. Deng G.M., Nilsson I.M., Verdrengh M., Collins L.V., Tarkowski A. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 1999, 5(6):702-705.
15. Segal B.M., Chang J.T., Shevach E.M. CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. J Immunol 2000, 164(11):5683-5688.
16. Lang K.S., Recher M., Junt T., Navarini A.A., Harris N.L., Freigang S., et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 2005, 11(2):138-145.
17. Kohm A.P., Carpentier P.A., Anger H.A., Miller S.D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002, 169(9):4712-4716.
18. Sean Riminton D., Körner H., Strickland D.H., Lemckert L.F.A., Pollard J.D., Sedgwick J.D., et al. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J Exp Med 1998, 187(9):1517-1528.
19. Song J.Y., Han S.K., Son E.H., Pyo S.N., Yun Y.S., Yi S.Y., et al. Induction of secretory and tumoricidal activities in peritoneal macrophages by ginsan. Int Immunopharmacol 2002, 2(7):857-865.
20. Jee Y., Piao W.H., Liu R., Bai X.F., Rhodes S., Rodebaugh R., et al. CD4+CD25+ regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin Immunol 2007, 125(1):34-42.
21. Reddy J., Illes Z., Zhang X., Encinas J., Pyrdol J., Nicholson L., et al. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2004, 101(43):15434-15439.
22. Wraith D.C., Nicolson K.S., Whitley N.T. Regulatory CD4+ T cells and the control of autoimmune disease. Curr Opin Immunol 2004, 16(6):695-701.
23. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4(4):330-336.
24. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299(5609):1057-1061.
25. Liu R., La Cava A., Bai X.F., Jee Y., Price M., Campagnolo D.I., et al. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. J Immunol 2005, 175(12):7898-7904.
26. Hansen B.S., Hussain R.Z., Lovett-Racke A.E., Thomas J.A., Racke M.K. Multiple Toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity. J Neuroimmunnol 2006, 172(1-2):94-103.
27. Wenink M.H., Santegoets K.C.M., Broen J.C., van Bon L., Abdollahi-Roodsaz S., Popa C., et al. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the Type I IFN amplication loop. J Immunol 2009, 183:6960-6970.
28. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., Murphy K.M. Th17: an effector CD4+ T cell lineage with regulatory T cell ties. Immunity 2006, 24(6):677-688.
29. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441(7090):235-238.
30. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441(7090):231-234.
31. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24(2):179-189.
32. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol 2002, 3:392-398.
33. Kebir H., Ifergan I., Alvarez J.I., Bernard M., Poirier J., Arbour N., et al. Preferential recruitment of interferon-gamma-expressing T(H)17 cells in multiple sclerosis. Ann Neurol 2009, 66:390-402.